Health Calls Traded? Shock Insider Story

Press podium with the White House sign and an American flag in the background
Photo: Frame Stock Footage / Shutterstock

A former insider just named names and described meetings where he says the people guarding the gate let industry walk right through.

Story Snapshot

  • Calley Means alleged that top aides shaped health policy to favor industry access and sought specific approvals.
  • He described a meeting linking a Moderna flu shot approval to broader policy cooperation.n
  • Susie Wiles, James Blair, and Continental Strategy denied core claims
  • Attorney General Todd Blanche dismissed calls for any Justice Department review

What Means says happened, and why it matters now

Calley Means, a former senior adviser and one-time aide to Robert F. Kennedy Jr., went on television and podcasts with a detailed story about how health policy got slow-walked or steered. He said Susie Wiles, a top White House official, and deputy James Blair pushed a path for fruit-flavored vapes and resisted other Make America Healthy Again ideas. He also called White House counselor Kellyanne O’Connor his largest obstacle to those efforts, citing specific meetings and asks.

Means claimed one meeting turned on a single trade. He said O’Connor told Health and Human Services Secretary Marty Makary she could not help with other policy goals unless he approved Moderna’s messenger ribonucleic acid flu shot, mFLUSIVA. He said Makary did not think the science supported approval and saw the push as wrong. This account, if accurate, points to leverage, not law, as the main force on life-and-death health calls.

The denials came fast and on the record.

Susie Wiles denied arranging a golf course sit-down between the president and tobacco players about flavored vapes. James Blair said he never promoted flavored vapes. Continental Strategy, speaking for Wiles’s daughter, said Means got the firm’s work wrong and denied lobbying on vape, kratom, or glyphosate. The White House also pushed back, calling the claims false and defamatory. These direct denials meet the named allegations head-on, but they do not,t by themselves,s settle the facts.

Attorney General Todd Blanche publicly brushed off the storm. He said he strongly disagreed with the idea that Wiles put other interests over the president’s. He also said the claims did not call for a Justice Department probe. He framed Means as a disgruntled former official and said that alone cannot drive action. That response echoes a common theme in Washington: sharp policy fights are normal; corruption claims, without files or money trails, are not enough.

The plays Means describes are old, but the roster is new.

Means’s story names an access channel: meetings, pressure points, and a loop of aides and outside firms. He ties this to flavored vapes, vaccine approval timing, and sugar research concerning kids. He says donors and lobbyists sought soft edges and slow brakes. Past tobacco battles show how lobbying, public relations, and front groups can bend the process long before a rule is signed, which gives his account a familiar ring even if the specific proof is not public yet.

Two points can be true at once. One, the allegations are not backed by released emails, calendars, or invoices in the record we have. Two, the details are specific enough to check. Conservative common sense says follow the paper: agendas, meeting notes, visitor logs, and drafts. If staff tied non-related approvals to other policy cooperation, that should show up in timelines and correspondence. If not, the claims fade in the light. Either way, clarity serves the public and the president.

What to watch next: receipts, timelines, and witnesses

Watch for documents from Health and Human Services and the Food and Drug Administration on the Moderna flu shot path. Look for White House and agency calendars that match Means’s meeting claims. Track any paper on flavored-vape policy development and whether outside voices shaped the route. If independent witnesses back the alleged meeting conditions, the story hardens. If the records show routine review and normal sequencing, this sail will deflate quickly.

Means chose a megaphone roll-out: Joe Rogan, Face the Nation, and fast pickup across outlets. That spreads the claims before the binders arrive. The cost is clear: heat rises faster than proof. But the benefit is also clear: witnesses and documents surface when the public is watching. If Congress wants answers, narrow requests will beat broad speeches. Ask for date-bounded communications on mFLUSIVA, flavored vapes, and child sugar policy. The result will either confirm pressure or clear the slate.

Bottom line for readers who want results, not drama

The test is simple and fair. Did staff link help on one policy to a yes on an unrelated drug decision. Did outside players gain a special lane on flavored vapes. Bring the records and let the facts talk. The attorney general has signaled no probe for now. That puts the burden on internal reviews and Congress. If the receipts match the words, fix the process. If they do not, close the book. Either outcome is better than a fog that helps no one.

Sources:

cbsnews.com